Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Benjian Gao(Southwest Medical University), Bo Li(Affiliated Hospital of Southwest Medical University), Hong Liu(Nanjing Medical University), Yunwei Han(Breast Cancer Research Foundation), Fengyi Yang(Affiliated Hospital of Southwest Medical University), Yongfa Liu(Affiliated Hospital of Southwest Medical University), Rui Wang(Southwest Medical University), Shuai Hu(Chengdu Medical College), Jie Liu(Dazhou Central Hospital), Jin Yang(Affiliated Hospital of Southwest Medical University), Yi Zhao(Affiliated Hospital of Southwest Medical University), Xiaoli Yang(Guilin Medical University), Cheng Fang(Zhejiang A & F University), Cheng Cui(Peking University), Dongning Zheng(Southwest Medical University), LinXin Liu(Affiliated Hospital of Southwest Medical University), Song Su(Affiliated Hospital of Southwest Medical University)
Cited by 10
Related Papers
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry
|Nature Metabolism|2020|304
NADP+-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance
|Molecular Cell|2015|247
The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein
|The Journal of Immunology|2010|235
Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification
|International Journal of Cardiology|2013|107
Activation of GPR81 by lactate drives tumour-induced cachexia
|Nature Metabolism|2024|100